FDBK
NEUTRALFeedback plc Announces Annual General Meeting Details
The clinical infrastructure specialist announces details for its upcoming Annual General Meeting, including the option for shareholders to attend online.
Feedback
10.35GBX
0.00%
Market Cap
4.53M
Volume
22.52k
63% of avg
P/E Ratio
-0.37
EPS (TTM)
-28
Beta
-0.07
Day Range
10.20p - 10.50p
52 Week Range
10.00p10.35p66.00p
10.35p
Upcoming Events
Early 2026
NHS 10-Year Plan publication
High Impact Event
Early 2027
Projected end of current cash runway
High Impact Event
FDBK
BADFeedback plc Reports Widening Losses Amid NHS Restructuring Challenges
The medical imaging firm reported widening losses and a 25% revenue decline amid NHS restructuring challenges. Despite a strong cash position, ongoing market uncertainties and contract delays pose significant headwinds.
FDBK
NEUTRALFeedback Plc Announces Results Presentation
The healthcare technology company will be announcing its annual results and hosting an investor presentation.
FDBK
NEUTRALFeedback Grants Options to PDMR
The clinical infrastructure specialist has granted options to a PDMR and other employees to incentivize and retain talent.
FDBK
NEUTRALFeedback plc Demonstrates Bleepa Platform in Neighbourhood Health Service Simulation
The clinical infrastructure specialist showcases its Bleepa platform as part of a simulation to test a new model for delivering integrated healthcare services in local communities.
FDBK
NEUTRALFeedback PLC Announces Holding Change
The healthcare technology company has announced a change in its major shareholder.
FDBK
NEUTRALFeedback PLC Announces Holding(s) in Company
The healthcare technology company has announced changes to its major shareholders.
FDBK
BADFeedback plc Faces Headwinds as NHS Restructuring Delays Contract Awards
The healthcare technology company faces headwinds as NHS restructuring delays contract awards, leading to a decline in expected revenue.
FDBK
GOODFeedback plc Reports Progress in Half-Year Results, Aligns with NHS Priorities
The clinical infrastructure specialist reported revenue growth and decreased losses in its half-year results. New contracts, partnerships, and alignment with NHS priorities position the company for future growth.
FDBK
NEUTRALFeedback plc Announces Upcoming Results and Investor Presentation
The healthcare technology company will release its half-year results and host investor and analyst presentations on 25 February 2025.